Skip to main content
SupplementScience
Bergamot (Citrus Bergamot) supplement
Citrus Polyphenol Extract

Bergamot (Citrus Bergamot): Benefits, Dosage, Forms & Research

Citrus Polyphenol Extract

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

Bergamot extract can lower LDL cholesterol by 20-30% and triglycerides by 20-25% in clinical studies, rivaling low-dose statin therapy. Its polyphenols also improve HDL function and blood glucose. Standard dosing is 500-1000mg bergamot polyphenolic fraction daily.

Key Facts

What it is
A polyphenol-rich extract from Citrus bergamia containing brutieridin and melitidin
Primary benefits
  • Reduces LDL cholesterol by 20-30%
  • Lowers triglycerides by 20-25%
  • Improves HDL cholesterol and function
  • Supports healthy blood glucose levels
  • Reduces oxidative stress markers
Typical dosage
500-1000mg bergamot polyphenolic fraction (BPF) daily
Evidence level
Moderate
Safety profile
Generally Safe

What the Research Says

Bergamot research has accelerated rapidly since the pivotal Mollace et al. (2011) study demonstrated impressive LDL and triglyceride reductions in hyperlipidemic patients. Gliozzi et al. (2014) extended these findings to metabolic syndrome, showing improvements across multiple cardiometabolic markers. The mechanisms are well-characterized: brutieridin and melitidin directly inhibit HMG-CoA reductase (the same target as statins), while other polyphenols activate AMPK and improve glucose uptake. Most studies use Calabrian bergamot extracts, and product quality varies significantly — standardized BPF from authenticated Citrus bergamia sources provides the most reliable results.

Benefits of Bergamot (Citrus Bergamot)

  • LDL cholesterol reduction — Mollace et al. (2011) found that 1000mg BPF daily reduced LDL by 36% after 30 days in patients with hyperlipidemia, with effects comparable to moderate-dose rosuvastatin.
  • Triglyceride lowering — the same study reported triglyceride reductions of 39% at the 1000mg dose, exceeding the effect typically seen with statin monotherapy.
  • HDL improvement — bergamot extract increased HDL cholesterol by 40% in the Mollace et al. trial, likely through enhanced reverse cholesterol transport and anti-oxidation of HDL particles.
  • Metabolic syndrome support — Gliozzi et al. (2014) demonstrated that bergamot polyphenols significantly improved fasting glucose, insulin sensitivity, and waist circumference in metabolic syndrome patients.
Did you know?

Bergamot research has accelerated rapidly since the pivotal Mollace et al.

Forms of Bergamot (Citrus Bergamot)

FormBioavailabilityBest For
Bergamot Polyphenolic Fraction (BPF)HighGold standard — the specific extract used in published clinical trials from Calabria
Bergamot Juice ExtractModerateWhole-food form — contains polyphenols plus fiber, but lower concentration per serving
Bergamot Essential Oil (oral)LowNot recommended for lipid management — aromatic use only; different compound profile than BPF

Dosage Recommendations

General recommendation: 500-1000mg bergamot polyphenolic fraction daily

Timing: Take before meals for optimal absorption

Dosage by Condition

ConditionRecommended DoseEvidence
Elevated LDL cholesterol500-1000mg BPF dailyModerate
Metabolic syndrome1000mg BPF dailyModerate
Statin adjunct therapy500mg BPF daily with low-dose statinModerate

Upper limit: 1500mg/day (limited data above 1000mg)

Side Effects and Safety

Safety profile: Generally Safe

Potential Side Effects

  • Mild GI discomfort (heartburn, nausea)
  • Muscle cramps at high doses (rare)
  • Photosensitivity with bergamot essential oil (not relevant for oral BPF extract)
  • Dizziness (uncommon)

Drug & Supplement Interactions

  • Statin drugs — additive cholesterol-lowering effects (may allow dose reduction under medical supervision)
  • Diabetes medications — may enhance blood glucose lowering; monitor levels
  • Anticoagulants — bergamot may have mild antiplatelet effects; use caution
Check Bergamot (Citrus Bergamot) interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

Related Supplements

Frequently Asked Questions

How does bergamot compare to red yeast rice for cholesterol?

Both bergamot and red yeast rice can lower LDL by 20-30%, but they work slightly differently. Red yeast rice contains monacolin K (identical to lovastatin), making it essentially a natural statin with similar side effect potential. Bergamot polyphenols inhibit the same enzyme but through different chemical interactions, and appear to have fewer muscle-related side effects. Bergamot may also offer stronger triglyceride reduction and HDL improvement. Some practitioners combine them at lower doses for broader lipid coverage.

Can I take bergamot alongside a statin?

Yes, and this is actually a promising approach. A study by Gliozzi et al. showed that combining bergamot with a low-dose statin (rosuvastatin 10mg) achieved lipid reductions comparable to high-dose statin monotherapy (rosuvastatin 20mg), potentially reducing statin side effects. However, always discuss combination therapy with your doctor, as additive effects on cholesterol synthesis need monitoring.

Is bergamot extract the same as bergamot essential oil?

No, they are very different products. Bergamot polyphenolic fraction (BPF) is a water-soluble extract from the juice and albedo (inner rind) of the bergamot fruit, rich in brutieridin and melitidin. Bergamot essential oil is steam-distilled from the peel and contains volatile terpenoids like limonene and linalool — it is used for aromatherapy and has no demonstrated cholesterol-lowering effects. Only BPF supplements have clinical evidence for cardiovascular benefits.

References

  1. (). Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia. DOI
  2. (). Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. International Journal of Cardiology. DOI